JOHN MLADUCKY: Open Payments
NPI 1033777362 · SOUTH PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 31 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $531 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $536 |
| Boston Scientific Corporation | 2 | $170 |
| Lilly USA, LLC | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Intercept Pharmaceuticals, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: RINVOQ, SKYRIZI, EXALT Model D, General - Biliary Devices, OMVOH, DUPIXENT, VOQUEZNA, LINZESS.
Industry payments across ME — which companies pay providers there.
